Ruth Geide

Senators Mull Ways to Stop Patent ‘Abuse’ by Pharma Companies

— Manufacturers of brand-name drugs will try every tack to delay generic entry, experts say by Shannon Firth , Washington Correspondent, MedPage Today May 21, 2024 Senators and experts on Tuesday examined the range of tools that brand-name drug manufacturers have used to keep generic and biosimilar competition at bay — from patent thickets and […]

Senators Mull Ways to Stop Patent ‘Abuse’ by Pharma Companies Read More »

Labor Department’s new salaried overtime rule: What healthcare leaders should know

Alexis Kayser (Email) –  Becker’s Hospital Review Effective July 1, salaried workers making less than $43,888 per year will qualify for 1.5 times pay if they work more than 40 hours per week, up from the current cusp of $35,568. On Jan. 1, the threshold will rise again to include salaried workers making less than

Labor Department’s new salaried overtime rule: What healthcare leaders should know Read More »

Lawmakers pitch expanded doula coverage in Medicaid

Rylee Wilson – Becker’s Payer Issues Federal lawmakers are proposing allowing Medicaid reimbursement of doulas and midwives in every state. Doula coverage varies by state. As of February, 13 states provide doula coverage through their Medicaid programs and another 12 are in the process of implementing coverage, according to a report from the Elevance Health

Lawmakers pitch expanded doula coverage in Medicaid Read More »

Do nonprofit hospitals sidestep FTC’s noncompete ban?

Alan Condon – Becker’s Hospital Review The Federal Trade Commission voted to implement a sweeping noncompete ban that would have seismic effects on the healthcare industry and the U.S. economy more broadly. But questions remain around which nonprofit hospitals and other providers may be affected by the ban and how far the FTC’s jurisdiction reaches

Do nonprofit hospitals sidestep FTC’s noncompete ban? Read More »

Who should have the final say in patients’ involuntary treatment?: Viewpoint

Mariah Taylor (Email) – Becker’s Clinical Leadership Many states require a court order to determine involuntary treatment, but independent committees could be a better way of meeting patients’ needs, Sandeep Jauhar, MD, PhD, a cardiologist in New York City-based Northwell Health wrote in an opinion piece published in The New York Times May 13. Dr.

Who should have the final say in patients’ involuntary treatment?: Viewpoint Read More »

The Online World Is a Double-Edged Sword for Youth Mental Health

— Here’s how to support young patients and their parents by Tiffany Munzer, MD May 14, 2024 John* is a 12-year-old boy with autism who was presenting to our clinic in the midst of a mental health crisis, with suicidal thoughts and school avoidance. Given the bullying he faced, attending school was causing him so

The Online World Is a Double-Edged Sword for Youth Mental Health Read More »

The case against retention bonuses

Alexis Kayser (Email) –  Becker’s Hospital Review Many health systems are zeroing in on bonus packages to stand out to potential recruits and incentivize current employees to stay — but some have their doubts about this tactic. Sign-on and retention bonuses have become increasingly popular in hospitals, according to recent surveys. Over the course of

The case against retention bonuses Read More »

What Clinicians Can Do About the Rise of the “Zombie Drug”

By Avneet Soin, MD April 22, 2024 Original article Featured in Op-Med, a collection of original articles contributed by Doximity members. Featured image for What Clinicians Can Do About the Rise of the “Zombie Drug” When I was in medical school, fentanyl was a major topic of conversation and training. The recent rise of another

What Clinicians Can Do About the Rise of the “Zombie Drug” Read More »